Co-Diagnostics
(NASDAQ) CODX
Co-Diagnostics Financials at a Glance
Market Cap
$4.13M
Revenue (TTM)
$507.89K
Net Income (TTM)
$32.18M
EPS (TTM)
$-28.73
P/E Ratio
-0.07
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$2.03
Volume
362,626.175
Open
$1.96
Price
$2.03
Volume
362,626.175
Open
$1.96
Previous Close
$2.02
Daily Range
$1.92 - $2.11
52-Week Range
$1.92 - $46.50
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$2.03
Volume
362,626.175
Open
$1.96
Previous Close
$2.02
Daily Range
$1.92 - $2.11
52-Week Range
$1.92 - $46.50
CODX News
Why Co-Diagnostics Is Soaring Today
CODX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Co-Diagnostics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
132
CEO
Dwight Howard Egan
Website
co-dx.comHeadquarters
Salt Lake City, UT 84109, US
CODX Financials
Key Financial Metrics (TTM)
Gross Margin
34%
Operating Margin
-70%
Net Income Margin
-63%
Return on Equity
-62%
Return on Capital
-87%
Return on Assets
-72%
Earnings Yield
-14.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.13M
Shares Outstanding
2.10M
Volume
362.63K
Short Interest
0.00%
Avg. Volume
2.75M
Financials (TTM)
Gross Profit
$2.92M
Operating Income
$40.08M
EBITDA
$38.70M
Operating Cash Flow
$29.16M
Capital Expenditure
$748.35K
Free Cash Flow
$29.90M
Cash & ST Invst.
$29.75M
Total Debt
$2.15M
Co-Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$145.38K
-77.3%
Gross Profit
$119.09K
-65.4%
Gross Margin
81.92%
N/A
Market Cap
$4.13M
N/A
Market Cap/Employee
$31.27K
N/A
Employees
132
N/A
Net Income
$5.89M
+39.3%
EBITDA
$6.75M
+31.7%
Quarterly Fundamentals
Net Cash
$9.97M
-71.7%
Accounts Receivable
$979.12K
+449.3%
Inventory
$1.09M
-13.9%
Long Term Debt
$727.94K
-50.6%
Short Term Debt
$744.16K
-17.0%
Return on Assets
-71.93%
N/A
Return on Invested Capital
-86.56%
N/A
Free Cash Flow
$5.98M
+19.2%
Operating Cash Flow
$5.90M
+18.3%